Nephron Pharmaceuticals, West Columbia, SC, has formed a partnership with One Medical, San Francisco, a national digital health and primary care organization that combines 24/7 access to virtual care and digital health tools with covid-19 testing services for businesses and their employees.
“Reopening businesses and getting our economy moving again is one of our highest priorities,” says Lou Kennedy, chief executive officer of Nephron Pharmaceuticals. “Part of the new normal for businesses is testing employees to make sure the workplace is safe. We couldn’t be prouder to offer covid-19 testing services to our employees and neighbors.”
Nephron’s CLIA-certified lab has state-of-the-art technology for covid-19 real-time PCR testing and serological antibody testing for its own employees and for the employees of neighboring businesses. The lab intends to integrate with One Medical’s technology platform, which is capable of supporting a comprehensive workplace reentry covid-19 testing program.
One Medical’s virtual care solutions facilitate scheduling for specimen collection and digitally documenting test results. It also screens and evaluates clinical risk factors and symptoms, and supports employer tracking and reporting.
“I am very pleased to be working alongside the Nephron team to leverage One Medical’s digital health platform as a way to help get South Carolinians back to work safely,” says John Singerling, chief network officer for One Medical. “Working with more than 7,000 employers nationwide has allowed One Medical to build a comprehensive workplace reentry program that is grounded in medicine and testing, and powered by our technology, which allows for seamless tracking, tracing, and ongoing monitoring.”
For more information, visit Nephron Pharmaceuticals and One Medical.
